ISRCTN15530806已完成不适用
Impact of low alcohol labels on consumption: a bar lab experiment
niversity of Cambridge0 个研究点目标入组 264 人开始时间: 2016年11月21日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 264
研究概览
简要总结
2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/29698021
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Adult men and women (above 18 years of age)
- •2. Weekly wine/beer drinker
排除标准
- •1. Under 18 years of age
- •2. Non-weekly wine/beer drinker
- •3. Pregnancy (women only)
- •4. Medication use (including antibiotics)
- •5. History of neurological or psychiatric disorders
研究者
相似试验
已完成
不适用
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY VolunteersCardiovascular DiseasesAtherosclerosisNCT03273972Cambridge University Hospitals NHS Foundation Trust30
进行中（未招募）
1 期
A Study to Evaluate the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Patients with Spinal Muscular Atrophy After Gene TherapyCTIS2023-504508-26-00F. Hoffmann-La Roche AG41
进行中（未招募）
1 期
A Study to Evaluate the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients with Spinal Muscular Atrophy who Experienced a Plateau or Decline in Function After Gene TherapySpinal Muscular Atrophy (SMA)MedDRA version: 20.1Level: LLTClassification code: 10051203Term: Spinal muscular atrophy congenital Class: 10010331MedDRA version: 20.1Level: PTClassification code: 10041582Term: Spinal muscular atrophy Class: 100000004850MedDRA version: 20.0Level: LLTClassification code: 10079417Term: Spinal muscular atrophy infantile onset Class: 10010331CTIS2023-505161-81-00F. Hoffmann-La Roche AG46
已完成
不适用
Lumenato Nutritional Supplement on Skin AppearanceSkinNCT04248699LycoRed Ltd.72
已完成
1 期
Evaluation of Abuse Liability of Very Low Nicotine (VLN) Mentholated CigarettesTobacco UseNCT0355972522nd Century Group, Inc.55